PMC6381888_01
Response to eculizumab treatment in mitomycin-C-induced TMA. Laboratory parameters over the course of treatment. Treatment periods are indicated by coloured bars: yellow, PE; green, rituximab; red, haemodialysis; blue, eculizumab. Day 0 represents TMA manifestation.
cro-0012-0001-g01.jpg
PMC6381888_01_cro-0012-0001-g01.jpg
F1
After 2 months, there was no clinical sign of improvement (Fig. 1).